Senior insider sale
Chief Financial Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$1.30M
257.46K shares
CALLICUTT JACK W plans to sell 257.46K shares of GALECTIN THERAPEUTICS INC valued at approximately $1.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
Equity Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/1/2026 | Restricted Stock Units Equity Compensation | 60K | — |
| Total | 60K | ||
Completed
Units to sell
46.31K
Market value
$287.8K
Units to sell
31.61K
Market value
$190.3K
Units to sell
5.29K
Market value
$31.9K
Units to sell
600.00
Market value
$3.6K
Units to sell
28.63K
Market value
$173.8K
Units to sell
3.81K
Market value
$22.9K
Planned — Approximate Date
Units to sell
141.21K
Market value
$593.1K
Units
257.46K
Value
$1.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/18/2025 | 46.31K | $287.8K | — | Completed |
11/17/2025 | 31.61K | $190.3K | — | Completed |
11/10/2025 | 5.29K | $31.9K | — | Completed |
11/5/2025 | 600.00 | $3.6K | — | Completed |
11/4/2025 | 28.63K | $173.8K | — | Completed |
11/3/2025 | 3.81K | $22.9K | — | Completed |
| Planned — Approximate Date | ||||
1/2/2026 | 141.21K | $593.1K | Nasdaq | Planned |
| Total | 257.46K | $1.30M | ||